Indications, timing and outcomes in 273 patients who underwent surgery for infective endocarditis
| Total (N=273) | |
| Surgical indications | |
| Congestive heart failure | 217 (79.5) |
| Prevention of embolism | 101 (37.0) |
| Paravalvular complications | 58 (21.2) |
| Uncontrolled infections | 19 (7.0) |
| Pacemaker infections | 7 (2.6) |
| Valve locations | |
| Mitral valve | 174 (63.7) |
| Aortic valve | 131 (48) |
| Tricuspid valve | 17 (6.2) |
| Pulmonary valve | 10 (3.7) |
| Multiple valves | 56 (20.5) |
| Timing of surgery | |
| Surgery within 24 hours | 12 (4.4) |
| Surgery within 2–7 days | 110 (40.3) |
| Surgery at >7 days | 151 (55.3) |
| EuroSCORE II (%) | 6.2 (4.7–9.3) |
| Replaced valve | |
| Mechanical valve | 184 (67.4) |
| Bioprosthetic valve | 68 (24.9) |
| Bentall operation | 5 (1.8) |
| Homograft | 3 (1.1) |
| Valve repair only | 18 (6.6) |
| Outcomes | |
| New-onset heart failure | 32 (11.7) |
| Acute renal failure | 29 (10.6) |
| New-onset conduction abnormality | 27 (9.9) |
| In-hospital mortality | 20 (7.3) |
| 30-day mortality | 10 (3.7) |
| 1-year mortality | 21 (7.7) |
Data are presented as median (IQR) or number (%) of patients.